<![CDATA[ctDNA Assay Shows High Specificity for Post-Transplant Liver Cancer Recurrence]]>

Data ReadoutpositivectDNA assayPositive

AI Analysis

Summary

A personalized ctDNA assay demonstrated 100% specificity for detecting liver cancer recurrence after transplantation in HCC and CCA patients, though sensitivity was limited. This data readout suggests potential clinical utility in post-transplant monitoring, though practical limitations may restrict broader adoption.

Outcome Details

100% specificity demonstrated, but limited sensitivity for detecting recurrence after liver transplantation in HCC and CCA

Importance:3/10

Sentiment:

0.60

ctDNAliver cancerHCCCCAtransplantationrecurrence detectionspecificitypersonalized medicine

Read the original article

Published by Cancer Network on September 28, 2026 6:00 PM

Read Original